A5111535364- Bipolar Disorder and Treatment
- Schizophrenia research and treatment
- Attention Deficit Hyperactivity Disorder
- Treatment of Major Depression
- Electroconvulsive Therapy Studies
- Youth Development and Social Support
- Motivation and Self-Concept in Sports
- Health and Well-being Studies
- Psychosocial Factors Impacting Youth
- Smart Grid and Power Systems
- Power Systems and Technologies
- Transportation and Mobility Innovations
- Human Health and Disease
- Infrastructure Resilience and Vulnerability Analysis
- Perfectionism, Procrastination, Anxiety Studies
- Fluorine in Organic Chemistry
- Nicotinic Acetylcholine Receptors Study
- Risk and Safety Analysis
- Neuroendocrine regulation and behavior
- Ophthalmology and Visual Impairment Studies
- Green IT and Sustainability
- Mental Health Research Topics
- Energy Load and Power Forecasting
- Tryptophan and brain disorders
- Sexual function and dysfunction studies
Beijing Union University
2024-2025
Henan Normal University
2024
Capital University of Physical Education and Sports
2024
University of Science and Technology
2024
Guangzhou Sport University
2024
Shanghai Electric (China)
2024
Vion Pharmaceuticals (United States)
2014-2023
Sunovion (United States)
2014-2023
Sunovion (United Kingdom)
2014
To explore the relationship between social support and adolescent athlete engagement role of self-efficacy mental toughness in this relationship. Participants methods: This study was a cross-sectional study. Convenience sampling method used, athletes from seven youth sports schools China were used as subjects. Five hundred thirteen valid questionnaires recovered, 264 (51.46%) males 249 (48.54%) females, mean age 17.8 ± 1.1 years. (1) After controlling for effects sport level, regression...
To evaluate the efficacy of lurasidone for schizophrenia using an established five-factor model Positive and Negative Syndrome Scale (PANSS).Patient-level data were pooled from five randomized, double-blind, placebo-controlled, 6-week studies (fixed doses, 40-160mg/d) patients with acute exacerbation schizophrenia. Changes in PANSS factors assessed mixed-model repeated measures analysis.Compared placebo (n=496), (n=1029, dose groups pooled) significantly improved total score at Week 6 (-22.6...
Abstract To explore the relationship between social support and adolescent athlete engagement role of self-efficacy mental toughness in this relationship. A convenience sampling method was used to administer athletes' received questionnaire, general scale, inventory, athletic questionnaire athletes seven youth sports schools China, 513 valid questionnaires were collected. 1) After controlling for effects age sport level, regression analyses revealed that positively predicted engagement; 2)...
Introduction Schizophrenia is a chronic disease; consequently, long-term maintenance of efficacy an important clinical goal. Objective To evaluate lurasidone as treatment for schizophrenia. Aims demonstrate with lurasidone. Methods Adult patients experiencing acute exacerbation schizophrenia received 12–24 weeks open-label (40–80 mg/d, flexibly dosed). Those who maintained stability ≥12 were randomized to placebo or dosed) and entered the 28-week, double-blind withdrawal phase. Results Of...
In the past ten years, fact that rate of myopia in China remains high has become main problem seriously endangers youths a teenagers' public health. Related data shows students' from Chinese middle or schools and colleges exceeded by 70%. The primary school risen to 40%, percent preschool children is up 2.5%. Therefore, it very important explore prevention strategies control reduce adolescents. From perspective healthy China, visual impairment not caused due attention, parents guardians lack...
Introduction Evidence indicates that manic symptoms, below the threshold for hypomania (mixed features), are common in individuals with major depressive disorder (MDD). Objectives/aims To evaluate effect of lurasidone on specific and based Montgomery Asberg Depression Rating Scale (MADRS) Young Mania (YMRS) items, patients MDD mixed features. Methods Patients meeting DSM-IV-TR criteria MDD, who presented 2–3 protocol-specified were randomized to 6 weeks double-blind treatment monotherapy...
Background This post-hoc analysis evaluated whether the efficacy of lurasidone in major depressive disorder (MDD) with mixed features is moderated by number and characteristics manic symptoms present at study baseline. Methods Patients meeting DSM-IV-TR criteria for MDD who presented two or three (consistent DSM–5 specifier) were randomly assigned to 6 weeks double-blind treatment either 20–60 mg/d ( n = 109) placebo 100). Finite mixture models applied identify latent class patterns 10...
Introduction Sexual dysfunction is common in major depressive disorder (MDD), and frequently worsened by antidepressant treatment. Objectives/aims To evaluate the effect of lurasidone on sexual functioning as measured Changes Functioning Questionnaire (CSFQ) patients with MDD mixed features. Methods Patients meeting DSM-IV-TR criteria for MDD, who presented 2 or 3 protocol-specified manic symptoms, were randomized to 6weeks double-blind treatment either monotherapy 20–60mg/d ( n =109)...
Introduction Information is not available on the maintenance efficacy of lurasidone in bipolar disorder. Objectives/aims To evaluate recurrence prevention plus lithium (Li) or valproate (VPA) for treatment Methods Patients with I disorder received up to 20 weeks open-label (20–80 mg/d) Li VPA. who achieved consistent clinical stability were randomized 28 double-blind placebo, Results A total 496 patients met stabilization criteria and adjunctive vs. placebo. Fewer group had any mood episode...